rss

Russia president Putin says have approved first Russian-produced coronavirus vaccine

Putin says that his daughter has been vaccinated from the coronavirus

Putin
  • Says that Russian health ministry has approved coronavirus vaccine developed by Moscow’s Gamaleya Institute
  • Says hopes Russia will start mass production of coronavirus vaccine
Take what you will and believe what you want from the headlines above, but this may lay the groundwork for other countries to start prepping their own “breakthroughs” sooner rather than later. As with everything related to the pandemic thus far, all it takes is for one country to set a precedent and the others will take that as an opportunity to follow.

Fauci says its likely there will be tens of million of vaccine doses by the end of this year

US infectious diseases expert Fauci speaking in an interview with Reuters

Expects a safe and effective vaccine will have received approval by the end of 2020
  • says there is a middle ground where the country can prudently open amid the coronavirus
  • says some sections of the country have done well but other parts are on fire
  • says he does expect a safe and effective vaccine to receive approval by year end
  • says manufacturers say a billion doses of vaccine will be available by the end of 2021
  • we will likely have tens of millions of doses of vaccine by the end of this year
  • he would be satisfied by a trial that included thousands of people and showed no signs of unexpected severe adverse events
  • he has not seen any indication of pressure from white house on vaccine
  •  says regulatory authorities have promised that safety and efficacy of vaccine will be paramount concern

US infectious diseases expert Fauci speaking in an interview with Reuters 

US strikes $2.1 billion coronavirus vaccine deal with Sanofi, GlaxoSmithKline

Sanofi, GSK selected for Operation Warp Speed

The deal will see the firms provide the US government with 100 million doses of the coronavirus vaccine, with the US to provide up to $2.1 billion for development, clinical trials, manufacturing and the delivery of the initial batch of doses.

The US will also have a further option for a supply of additional 500 million doses of the vaccine in the longer-term. GSK adds that if study data are postive, the companies can request US regulatory approval some time in 1H 2021.
To put a bit of a timeline on things, phase 1/2 of the study is expected to start in September with Phase 3 set to be conducted by the end of the year.
That’s another win for both firms after having struck a deal with the UK government earlier in the week here.

More info on that Russian COVID-19 vaccine: 30 million doses in Russia by end of year and 170 million worldwide

The Russian vaccine speculation is not new, but here is more on it if you need.

Head of its sovereign wealth fund Kirill Dmitriev, chief executive of the Russian Direct Investment Fund, which is financing the country’s vaccine research:
  • Russia aims to secure approval for the first Covid-19 vaccine in the first two weeks of August
  • expects to produce 30 million doses in Russia by end of year and 170 million worldwide
The Russian vaccine speculation is not new, but here is more on it if you need.

Fauci: Some places may want to pause reopening, go back

Speaking on Fox News

Dr. Fauci is speaking on Fox news and says:
  • Some places may want to pause reopening, go back
  • He has a good relationship with Trump
  • some southern states need to step back on reopening
  • US shutdown was about 50% in reality, EU is 90%
  • footballs return is more complicated than baseball
  • he supports CDC’s school reopening guidelines
  • task force members are getting the message out
  • vaccine seen widely available by several months into 2021
Yesterday threw out the first pitch in Washington DC before the game between the Washington Nationals and the New York Yankees. He is obviously spending too much time focused on infection control.
  • By the end of this year/beginning of next year we will see if vaccine is safe and effective
  • Vaccine will be widely available several months into 2021

Some positive comments on vaccines from infectious disease expert Dr. Fauci

Pfizer/BionTech announce positive vaccine study results

Update from German Phase 1 and Phase 2 studies

Pfizer/BionTech have announced positive vaccine study results for their German phase I and phase II studies.
According to the companies the results showed a strong t-cell . The results expands upon early results from their US trial. There were no serious adverse events reported.

Fauci says will have an effective COVID-19 vaccine by the end of 2020

Anthony Fauci speaking with Reuters on the coronavirus

  • Says that US will have an effective coronavirus vaccine by year-end
  • Moderna’s vaccine trial results were especially promising
  • He does not think China will be first with a vaccine, at least not by much
Anthony Fauci speaking with Reuters on the coronavirus

S&P index leads the way. NASDAQ lags but closes higher for the 2nd straight day

S&P index closes just below breakeven level for 2020

The US stocks are ending the session with gains across the board. The gains are led by the S&P index which rose by 0.91%. The NASDAQ index lagged, but still gained 0.59%.

For the S&P index, it toyed with closing above the breakeven level for the year for the 1st time since February 25. However, that quest failed. The index is ending the day 0.13% from that breakeven level (2019 closes at 3230.78 while the close today is at 3226.56).

This week there has been a rotation out of the high flying tech stocks vs. the broader/industrial stocks. For the last 5 trading days the Dow industrial average is up 3.08% and the S&P index is up 1.79%, while the tech heavy NASDAQ index is up only 0.55%.
Nevertheless both the NASDAQ and the S&P index are up for 2 consecutive days. The Dow is riding a 4 day win streak.
The final numbers are showing:
  • S&P index +29.03 points or 0.91% at 3226.55
  • NASDAQ index up 61.915 points or 0.59% at 10550.49
  • Dow up 227.51 points or 0.85% at 26870.10.
Will tomorrow be the day for the S&P index to close the black? Maybe, but going forward headline news from more earnings releases, coronavirus cases, vaccines and therapeutics will continue to exert their influences. Each of which could upset the apple cart in a bullish or bearish direction.
Go to top